TCM
SPHS

Tang Capital Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Tang Capital Management’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-500,000
Closed -$1.85M – 16
2013
Q4 		$1.85M Hold
500,000
– – 1.29% 10
2013
Q3 		$2.34M Buy
+500,000
New +$2.31M 1.16% 14

Other funds holding SPHS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
SC
Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

Tang Capital Management's SPHS Position: Q1 2014 in Review

Tang Capital Management sold out of Sophiris Bio, Inc. (SPHS) in Q1 2014, closing a stake of 500,000 shares — an estimated $1.85M sold.

Tang Capital Management first reported a position in SPHS in Q3 2013 and held it in 2 quarters. The position peaked at $2.34M in Q3 2013. 24 funds tracked by Wall St. Rank hold SPHS as of Q1 2014.

  • Tang Capital Management reported no remaining Sophiris Bio, Inc. position as of Q1 2014 after selling out during the quarter.
  • Tang Capital Management sold 500,000 Sophiris Bio, Inc. shares in Q1 2014, an estimated $1.85M.
  • Tang Capital Management first reported a position in Sophiris Bio, Inc. in Q3 2013 and held it in 2 quarters.
  • Tang Capital Management's Sophiris Bio, Inc. position peaked at $2.34M in Q3 2013.
  • 24 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2014.

Based on Tang Capital Management's 13F filing for Q1 2014, filed 15 May 2014.